US Patent Issued to Celldex Therapeutics on May 13 for "Agonistic antibodies that bind human CD40 and uses thereof" (Pennsylvania, New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,266, issued on May 13, was assigned to Celldex Therapeutics Inc. (Hampton, N.J.).

"Agonistic antibodies that bind human CD40 and uses thereof" was invented by Tibor Keler (Pipersville, Pa.), Joel Goldstein (Hopewell, N.J.), Laura A. Vitale (Doylestown, Pa.), Lizhen He (Allentown, Pa.), Tom O'Neill (Washington, N.J.), Andrea Crocker (New Hope, Pa.), Karuna Sundarapandiyan (Kendall Park, N.J.), Lawrence J. Thomas (Easton, Mass.) and Jenifer Widger (Alpha, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Isolated monoclonal agonistic antibodies which bind to human CD40 and related antibody-based compositions and molecules are disclosed. Also disclos...